1. IL-3 and GM-CSF modulate functions of splenic macrophages in ENU induced leukemia
   Ashish Kumar Singha et al, 2017, Cytokine CrossRef
2. 5 years of clinical DC-CIK/NK cells immunotherapy for acute myeloid leukemia – a summary
   Xian Zhang et al, 2020, Immunotherapy CrossRef
3. Allogeneic hematopoietic stem cell transplantation following donor CIK cell infusion: A phase I study in patients with relapsed/refractory hematologic malignancies
   Yun Luo et al, 2016, Leukemia Research CrossRef
4. Therapeutic outcomes of autologous CIK cells as a maintenance therapy in the treatment of lung cancer patients: A retrospective study
   Hu Luo et al, 2016, Biomedicine & Pharmacotherapy CrossRef
5. Clinical application of cytokine-induced killer (CIK) cell therapy in colorectal cancer: Current strategies and future challenges
   Celine Man Ying Li et al, 2024, Cancer Treatment Reviews CrossRef
6. The rising role of natural killer cells in patients with malignant hematological disorders and in recipients of hematopoietic stem cell transplantation
   KA* Al-Anazi, 2019, Journal of Stem Cell Therapy and Transplantation CrossRef
7. Augmented CD3+CD8+ and CD3+CD56− cells in cytokine-induced killer cells cultured with engineered cells for costimulatory enhancement from heavily pretreated patients with solid tumor
   Lili Wang et al, 2016, Cytotherapy CrossRef
8. Dendritic cell/cytokine‐induced killer cell‐based immunotherapy in lung cancer: What we know and future landscape
   Monireh Mohsenzadegan et al, 2020, Journal of Cellular Physiology CrossRef
9. Autologous cytokine-induced killer cell immunotherapy may improve overall survival in advanced malignant melanoma patients
   Yong Zhang et al, 2017, Immunotherapy CrossRef
10. Induced Pluripotent Stem Cell-Derived Natural Killer Cells for Treatment of Ovarian Cancer
    David L. Hermanson et al, 2016, Stem Cells CrossRef
11. Update on Immunotherapy in AML and MDS: Monoclonal Antibodies and Checkpoint Inhibitors Paving the Road for Clinical Practice
    Lucia Masarova et al, 2018, Immunotherapy CrossRef
12. Novel Therapies for Acute Myeloid Leukemia: Are We Finally Breaking the Deadlock?
    Maximilian Stahl et al, 2017, Targeted Oncology CrossRef
13. Immunotherapy in acute myeloid leukemia and myelodysplastic syndromes: The dawn of a new era?
    Yuxin Liu et al, 2019, Blood Reviews CrossRef
14. IL-15 and GM-CSF stimulated macrophages enhances phagocytic activity in ENU induced leukemic mice
    Ashish Kumar Singha et al, 2020, Immunobiology CrossRef